Cape Verde vs South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB
Cape Verde
100.0%
in 2022
South-East Asia (WHO region)
77.0%
in 2022
Cape Verde rank
1st
South-East Asia (WHO region) rank
2nd
Treatment success rate for patients treated for MDR-TB over time
- Cape Verde
- South-East Asia (WHO region)
How they compare
Cape Verde currently reports 100.0% against 77.0% in South-East Asia (WHO region), a difference of 23.0%.
That makes Cape Verde's figure about 1.3 times South-East Asia (WHO region)'s.
Across all 6 years both countries report, Cape Verde has been ahead every year.
Cape Verde ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.
Cape Verde has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cape Verde | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 55.0% | 45.0% | Cape Verde |
| 2020s | 100.0% | 75.0% | 25.0% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Cape Verde or South-East Asia (WHO region)?
- Cape Verde, at 100.0% against 77.0% in South-East Asia (WHO region) as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Cape Verde and South-East Asia (WHO region)?
- 23.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and South-East Asia (WHO region)?
- 6 years are reported by both, from 2014 to 2022.
- How do Cape Verde and South-East Asia (WHO region) rank globally for treatment success rate for patients treated for mdr-tb?
- Cape Verde ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.